Table of Contents 1 Market Overview 1.1 Flu Vaccine Introduction 1.2 Market Analysis by Type 1.2.1 Whole Virus Vaccines 1.2.2 Split Virus Vaccines 1.2.3 Subunit Vaccines 1.2.4 Live Attenuated Virus Vaccines 1.3 Market Analysis by Applications 1.3.1 For Children (6 months to 3 years) 1.3.2 For Adults and Children over 3 years 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market States and Outlook (2012-2022) 1.4.1.2 Canada Market States and Outlook (2012-2022) 1.4.1.3 Mexico Market States and Outlook (2012-2022) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2012-2022) 1.4.2.2 France Market States and Outlook (2012-2022) 1.4.2.3 UK Market States and Outlook (2012-2022) 1.4.2.4 Russia Market States and Outlook (2012-2022) 1.4.2.5 Italy Market States and Outlook (2012-2022) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2012-2022) 1.4.3.2 Japan Market States and Outlook (2012-2022) 1.4.3.3 Korea Market States and Outlook (2012-2022) 1.4.3.4 India Market States and Outlook (2012-2022) 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2012-2022) 1.4.4.2 Egypt Market States and Outlook (2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022) 1.4.4.4 South Africa Market States and Outlook (2012-2022) 1.4.4.5 Nigeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 CSL 2.1.1 Business Overview 2.1.2 Flu Vaccine Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 GSK 2.2.1 Business Overview 2.2.2 Flu Vaccine Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Sanofi Pasteur 2.3.1 Business Overview 2.3.2 Flu Vaccine Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Mylan 2.4.1 Business Overview 2.4.2 Flu Vaccine Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 AstraZeneca 2.5.1 Business Overview 2.5.2 Flu Vaccine Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Pfizer 2.6.1 Business Overview 2.6.2 Flu Vaccine Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Johnson & Johnson 2.7.1 Business Overview 2.7.2 Flu Vaccine Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Flu Vaccine Market Competition, by Manufacturer 3.1 Global Flu Vaccine Sales and Market Share by Manufacturer 3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Flu Vaccine Manufacturer Market Share 3.3.2 Top 6 Flu Vaccine Manufacturer Market Share 3.4 Market Competition Trend 4 Global Flu Vaccine Market Analysis by Regions 4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions 4.1.1 Global Flu Vaccine Sales by Regions (2012-2017) 4.1.2 Global Flu Vaccine Revenue by Regions (2012-2017) 4.2 North America Flu Vaccine Sales and Growth (2012-2017) 4.3 Europe Flu Vaccine Sales and Growth (2012-2017) 4.4 Asia-Pacific Flu Vaccine Sales and Growth (2012-2017) 4.5 South America Flu Vaccine Sales and Growth (2012-2017) 4.6 Middle East and Africa Flu Vaccine Sales and Growth (2012-2017) 5 North America Flu Vaccine by Countries 5.1 North America Flu Vaccine Sales, Revenue and Market Share by Countries 5.1.1 North America Flu Vaccine Sales by Countries (2012-2017) 5.1.2 North America Flu Vaccine Revenue by Countries (2012-2017) 5.2 USA Flu Vaccine Sales and Growth (2012-2017) 5.3 Canada Flu Vaccine Sales and Growth (2012-2017) 5.4 Mexico Flu Vaccine Sales and Growth (2012-2017) 6 Europe Flu Vaccine by Countries 6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Countries 6.1.1 Europe Flu Vaccine Sales by Countries (2012-2017) 6.1.2 Europe Flu Vaccine Revenue by Countries (2012-2017) 6.2 Germany Flu Vaccine Sales and Growth (2012-2017) 6.3 UK Flu Vaccine Sales and Growth (2012-2017) 6.4 France Flu Vaccine Sales and Growth (2012-2017) 6.5 Russia Flu Vaccine Sales and Growth (2012-2017) 6.6 Italy Flu Vaccine Sales and Growth (2012-2017) 7 Asia-Pacific Flu Vaccine by Countries 7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Flu Vaccine Sales by Countries (2012-2017) 7.1.2 Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017) 7.2 China Flu Vaccine Sales and Growth (2012-2017) 7.3 Japan Flu Vaccine Sales and Growth (2012-2017) 7.4 Korea Flu Vaccine Sales and Growth (2012-2017) 7.5 India Flu Vaccine Sales and Growth (2012-2017) 7.6 Southeast Asia Flu Vaccine Sales and Growth (2012-2017) 8 South America Flu Vaccine by Countries 8.1 South America Flu Vaccine Sales, Revenue and Market Share by Countries 8.1.1 South America Flu Vaccine Sales by Countries (2012-2017) 8.1.2 South America Flu Vaccine Revenue by Countries (2012-2017) 8.2 Brazil Flu Vaccine Sales and Growth (2012-2017) 8.3 Argentina Flu Vaccine Sales and Growth (2012-2017) 8.4 Columbia Flu Vaccine Sales and Growth (2012-2017) 9 Middle East and Africa Flu Vaccine by Countries 9.1 Middle East and Africa Flu Vaccine Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Flu Vaccine Sales by Countries (2012-2017) 9.1.2 Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017) 9.2 Saudi Arabia Flu Vaccine Sales and Growth (2012-2017) 9.3 UAE Flu Vaccine Sales and Growth (2012-2017) 9.4 Egypt Flu Vaccine Sales and Growth (2012-2017) 9.5 Nigeria Flu Vaccine Sales and Growth (2012-2017) 9.6 South Africa Flu Vaccine Sales and Growth (2012-2017) 10 Global Flu Vaccine Market Segment by Type 10.1 Global Flu Vaccine Sales, Revenue and Market Share by Type (2012-2017) 10.1.1 Global Flu Vaccine Sales and Market Share by Type (2012-2017) 10.1.2 Global Flu Vaccine Revenue and Market Share by Type (2012-2017) 10.2 Whole Virus Vaccines Sales Growth and Price 10.2.1 Global Whole Virus Vaccines Sales Growth (2012-2017) 10.2.2 Global Whole Virus Vaccines Price (2012-2017) 10.3 Split Virus Vaccines Sales Growth and Price 10.3.1 Global Split Virus Vaccines Sales Growth (2012-2017) 10.3.2 Global Split Virus Vaccines Price (2012-2017) 10.4 Subunit Vaccines Sales Growth and Price 10.4.1 Global Subunit Vaccines Sales Growth (2012-2017) 10.4.2 Global Subunit Vaccines Price (2012-2017) 10.5 Live Attenuated Virus Vaccines Sales Growth and Price 10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2012-2017) 10.5.2 Global Live Attenuated Virus Vaccines Price (2012-2017) 11 Global Flu Vaccine Market Segment by Application 11.1 Global Flu Vaccine Sales Market Share by Application (2012-2017) 11.2 For Children (6 months to 3 years) Sales Growth (2012-2017) 11.3 For Adults and Children over 3 years Sales Growth (2012-2017) 12 Flu Vaccine Market Forecast (2017-2022) 12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2017-2022) 12.2 Flu Vaccine Market Forecast by Regions (2017-2022) 12.2.1 North America Flu Vaccine Market Forecast (2017-2022) 12.2.2 Europe Flu Vaccine Market Forecast (2017-2022) 12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2017-2022) 12.2.4 South America Flu Vaccine Market Forecast (2017-2022) 12.2.5 Middle East and Africa Flu Vaccine Market Forecast (2017-2022) 12.3 Flu Vaccine Market Forecast by Type (2017-2022) 12.4 Flu Vaccine Market Forecast by Application (2017-2022) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Flu Vaccine Picture Table Product Specifications of Flu Vaccine Figure Global Sales Market Share of Flu Vaccine by Types in 2016 Table Flu Vaccine Types for Major Manufacturers Figure Whole Virus Vaccines Picture Figure Split Virus Vaccines Picture Figure Subunit Vaccines Picture Figure Live Attenuated Virus Vaccines Picture Table Flu Vaccine Sales Market Share by Applications in 2016 Figure For Children (6 months to 3 years) Picture Figure For Adults and Children over 3 years Picture Figure USA Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Canada Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Mexico Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Germany Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure France Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure UK Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Russia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Italy Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure China Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Japan Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Korea Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure India Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Brazil Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Flu Vaccine Revenue (Value) and Growth Rate (2012-2022) Table CSL Basic Information, Manufacturing Base and Competitors Table CSL Flu Vaccine Type and Applications Table CSL Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GSK Basic Information, Manufacturing Base and Competitors Table GSK Flu Vaccine Type and Applications Table GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors Table Sanofi Pasteur Flu Vaccine Type and Applications Table Sanofi Pasteur Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan Flu Vaccine Type and Applications Table Mylan Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Flu Vaccine Type and Applications Table AstraZeneca Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Flu Vaccine Type and Applications Table Pfizer Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Flu Vaccine Type and Applications Table Johnson & Johnson Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Flu Vaccine Sales by Manufacturer (2016-2017) Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2016 Figure Global Flu Vaccine Sales Market Share by Manufacturer in 2017 Table Global Flu Vaccine Revenue by Manufacturer (2016-2017) Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2016 Figure Global Flu Vaccine Revenue Market Share by Manufacturer in 2017 Figure Global Flu Vaccine Sales and Growth (2012-2017) Figure Global Flu Vaccine Revenue and Growth (2012-2017) Table Global Flu Vaccine Sales by Regions (2012-2017) Table Global Flu Vaccine Sales Market Share by Regions (2012-2017) Table Global Flu Vaccine Revenue by Regions (2012-2017) Table Global Flu Vaccine Revenue Market Share by Regions in 2012 Table Global Flu Vaccine Revenue Market Share by Regions in 2016 Figure North America Flu Vaccine Sales and Growth (2012-2017) Figure Europe Flu Vaccine Sales and Growth (2012-2017) Figure Asia-Pacific Flu Vaccine Sales and Growth (2012-2017) Figure South America Flu Vaccine Sales and Growth (2012-2017) Figure Middle East and Africa Flu Vaccine Sales and Growth (2012-2017) Figure North America Flu Vaccine Revenue and Growth (2012-2017) Table North America Flu Vaccine Sales by Countries (2012-2017) Table North America Flu Vaccine Sales Market Share by Countries (2012-2017) Figure North America Flu Vaccine Sales Market Share by Countries in 2012 Figure North America Flu Vaccine Sales Market Share by Countries in 2016 Table North America Flu Vaccine Revenue by Countries (2012-2017) Table North America Flu Vaccine Revenue Market Share by Countries (2012-2017) Figure North America Flu Vaccine Revenue Market Share by Countries in 2012 Figure North America Flu Vaccine Revenue Market Share by Countries in 2016 Figure USA Flu Vaccine Sales and Growth (2012-2017) Figure Canada Flu Vaccine Sales and Growth (2012-2017) Figure Mexico Flu Vaccine Sales and Growth (2012-2017) Figure Europe Flu Vaccine Revenue and Growth (2012-2017) Table Europe Flu Vaccine Sales by Countries (2012-2017) Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017) Table Europe Flu Vaccine Revenue by Countries (2012-2017) Table Europe Flu Vaccine Revenue Market Share by Countries in 2012 Table Europe Flu Vaccine Revenue Market Share by Countries in 2016 Figure Germany Flu Vaccine Sales and Growth (2012-2017) Figure UK Flu Vaccine Sales and Growth (2012-2017) Figure France Flu Vaccine Sales and Growth (2012-2017) Figure Russia Flu Vaccine Sales and Growth (2012-2017) Figure Italy Flu Vaccine Sales and Growth (2012-2017) Figure Asia-Pacific Flu Vaccine Revenue and Growth (2012-2017) Table Asia-Pacific Flu Vaccine Sales by Countries (2012-2017) Table Asia-Pacific Flu Vaccine Sales Market Share by Countries (2012-2017) Table Asia-Pacific Flu Vaccine Sales Market Share by Countries (2012-2017) Table Asia-Pacific Flu Vaccine Revenue by Countries (2012-2017) Table Asia-Pacific Flu Vaccine Revenue Market Share by Countries (2012-2017) Figure China Flu Vaccine Sales and Growth (2012-2017) Figure Japan Flu Vaccine Sales and Growth (2012-2017) Figure Korea Flu Vaccine Sales and Growth (2012-2017) Figure India Flu Vaccine Sales and Growth (2012-2017) Figure Southeast Asia Flu Vaccine Sales and Growth (2012-2017) Figure South America Flu Vaccine Revenue and Growth (2012-2017) Table South America Flu Vaccine Sales by Countries (2012-2017) Table South America Flu Vaccine Sales Market Share by Countries (2012-2017) Figure South America Flu Vaccine Sales Market Share by Countries in 2016 Table South America Flu Vaccine Revenue by Countries (2012-2017) Table South America Flu Vaccine Revenue Market Share by Countries (2012-2017) Figure South America Flu Vaccine Revenue Market Share by Countries in 2012 Figure South America Flu Vaccine Revenue Market Share by Countries in 2016 Figure Brazil Flu Vaccine Sales and Growth (2012-2017) Figure Argentina Flu Vaccine Sales and Growth (2012-2017) Figure Columbia Flu Vaccine Sales and Growth (2012-2017) Figure Middle East and Africa Flu Vaccine Revenue and Growth (2012-2017) Table Middle East and Africa Flu Vaccine Sales by Countries (2012-2017) Table Middle East and Africa Flu Vaccine Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2016 Table Middle East and Africa Flu Vaccine Revenue by Countries (2012-2017) Table Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2012 Figure Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2016 Figure Saudi Arabia Flu Vaccine Sales and Growth (2012-2017) Figure UAE Flu Vaccine Sales and Growth (2012-2017) Figure Egypt Flu Vaccine Sales and Growth (2012-2017) Figure Nigeria Flu Vaccine Sales and Growth (2012-2017) Figure South Africa Flu Vaccine Sales and Growth (2012-2017) Table Global Flu Vaccine Sales by Type (2012-2017) Table Global Flu Vaccine Sales Share by Type (2012-2017) Table Global Flu Vaccine Revenue by Type (2012-2017) Table Global Flu Vaccine Revenue Share by Type (2012-2017) Figure Global Whole Virus Vaccines Sales Growth (2012-2017) Figure Global Whole Virus Vaccines Price (2012-2017) Figure Global Split Virus Vaccines Sales Growth (2012-2017) Figure Global Split Virus Vaccines Price (2012-2017) Figure Global Subunit Vaccines Sales Growth (2012-2017) Figure Global Subunit Vaccines Price (2012-2017) Figure Global Live Attenuated Virus Vaccines Sales Growth (2012-2017) Figure Global Live Attenuated Virus Vaccines Price (2012-2017) Table Global Flu Vaccine Sales by Application (2012-2017) Table Global Flu Vaccine Sales Share by Application (2012-2017) Figure Global For Children (6 months to 3 years) Sales Growth (2012-2017) Figure Global For Adults and Children over 3 years Sales Growth (2012-2017) Figure Global Flu Vaccine Sales, Revenue and Growth Rate (2017 -2022) Table Global Flu Vaccine Sales Forecast by Regions (2017-2022) Table Global Flu Vaccine Market Share Forecast by Regions (2017-2022) Figure North America Sales Flu Vaccine Market Forecast (2017-2022) Figure Europe Sales Flu Vaccine Market Forecast (2017-2022) Figure Asia-Pacific Sales Flu Vaccine Market Forecast (2017-2022) Figure South America Sales Flu Vaccine Market Forecast (2017-2022) Figure Middle East and Africa Sales Flu Vaccine Market Forecast (2017-2022) Table Global Flu Vaccine Sales Forecast by Type (2017-2022) Table Global Flu Vaccine Market Share Forecast by Type (2017-2022) Table Global Flu Vaccine Sales Forecast by Application (2017-2022) Table Global Flu Vaccine Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List